Early albumin for kidney injury in cirrhosis
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently in the hospital.
- You have been diagnosed with advanced liver disease (decompensated cirrhosis).
- You have a sudden kidney problem (acute kidney injury) that started in the last week.
- You are not in the ICU, on a breathing machine, or needing more than 2 liters of extra oxygen.
- You have not had a liver or kidney transplant before.
- You do not have severe confusion from liver disease, active heavy bleeding, or severe heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving albumin (a blood protein) in a personalized dose works better than a standard fixed dose for people with cirrhosis and sepsis-related acute kidney injury. The goal is to find a safer and more effective way to protect kidney function.
This trial tests whether giving albumin (a blood protein through an IV) can improve recovery after acute kidney injury in people who are in the ICU and need kidney support treatment. It mainly aims to help the kidneys bounce back better after this serious illness.
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
This study tests whether giving albumin (a protein in the blood) before heart surgery helps protect the kidneys of young children with low albumin levels. It may help reduce the risk of kidney injury after surgery.
This study looks at whether certain proteins in the urine (albumin) can help predict if a person with acute heart failure will develop sudden kidney injury while in the ICU. It aims to find early warning signs to improve care.
This trial tests whether giving albumin through a vein is better than saline (salt water) for treating a sudden kidney injury in people with cirrhosis. The goal is to see which fluid helps the kidneys recover more effectively.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.